Table 1.

Summary of infection and cytopenia events

0.4 mg/kg weekly (n = 143)0.8 mg/kg EOW (n = 145)Prior TCR (n = 51)
Infections, n (%) 
Any grade 84 (58.7) 96 (66.2) 37 (72.5) 
Grade 3/4 31 (21.7) 23 (15.9) 14 (27.5) 
Led to death 3 (2.1) 2 (1.4) 
Led to discontinuation 2 (1.4) 1 (2.0) 
Led to dose interruption 45 (31.5) 49 (33.8) 19 (37.3) 
Neutropenia, n (%) 
Any grade 50 (35.0) 41 (28.3) 28 (54.9) 
Grade 3/4 neutropenia 44 (30.8) 32 (22.1) 27 (52.9) 
Any infection + concomitant grade 3/4 neutropenia 11 (7.7) 3 (2.1) 9 (17.6) 
Grade 3/4 infection + concomitant grade 3/4 neutropenia 4 (2.8) 1 (0.7) 1 (2.0) 
Anemia, n (%) 
Any grade 64 (44.8) 66 (45.5) 25 (49.0) 
Grade 3/4 45 (31.5)  40 (27.6)  14 (27.5)  
Lymphopenia, n (%)    
Any grade 40 (28.0) 42 (29.0) 9 (17.6) 
Grade 3/4 37 (25.9) 39 (26.9) 7 (13.7) 
Thrombocytopenia, n (%)    
Any grade 39 (27.3) 43 (29.7) 19 (37.3) 
Grade 3/4 29 (20.3) 27 (18.6) 15 (29.4) 
Leukopenia, n (%)    
Any grade 23 (16.1) 27 (18.6) 12 (23.5) 
Grade 3/4 11 (7.7) 18 (12.4) 9 (17.6) 
0.4 mg/kg weekly (n = 143)0.8 mg/kg EOW (n = 145)Prior TCR (n = 51)
Infections, n (%) 
Any grade 84 (58.7) 96 (66.2) 37 (72.5) 
Grade 3/4 31 (21.7) 23 (15.9) 14 (27.5) 
Led to death 3 (2.1) 2 (1.4) 
Led to discontinuation 2 (1.4) 1 (2.0) 
Led to dose interruption 45 (31.5) 49 (33.8) 19 (37.3) 
Neutropenia, n (%) 
Any grade 50 (35.0) 41 (28.3) 28 (54.9) 
Grade 3/4 neutropenia 44 (30.8) 32 (22.1) 27 (52.9) 
Any infection + concomitant grade 3/4 neutropenia 11 (7.7) 3 (2.1) 9 (17.6) 
Grade 3/4 infection + concomitant grade 3/4 neutropenia 4 (2.8) 1 (0.7) 1 (2.0) 
Anemia, n (%) 
Any grade 64 (44.8) 66 (45.5) 25 (49.0) 
Grade 3/4 45 (31.5)  40 (27.6)  14 (27.5)  
Lymphopenia, n (%)    
Any grade 40 (28.0) 42 (29.0) 9 (17.6) 
Grade 3/4 37 (25.9) 39 (26.9) 7 (13.7) 
Thrombocytopenia, n (%)    
Any grade 39 (27.3) 43 (29.7) 19 (37.3) 
Grade 3/4 29 (20.3) 27 (18.6) 15 (29.4) 
Leukopenia, n (%)    
Any grade 23 (16.1) 27 (18.6) 12 (23.5) 
Grade 3/4 11 (7.7) 18 (12.4) 9 (17.6) 

Percentages are calculated with the number of patients in the all-treated analysis set in each cohort as the denominator.

Grade 3 only.

or Create an Account

Close Modal
Close Modal